The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eaton, M. D.
Right arrow Articles by Pearson, H. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Eaton, M. D.
Right arrow Articles by Pearson, H. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
The Journal of Experimental Medicine, Vol 72, 635-643, Copyright, 1940, by The Rockefeller Institute for Medical Research New York

ARTICLE

QUANTITATIVE ASPECTS OF HOMOLOGOUS AND HETEROLOGOUS ACTIVE IMMUNITY TO STRAINS OF THE VIRUS OF EPIDEMIC INFLUENZA

Monroe D. Eaton M.D.1 and Harold E. Pearson M.D.1

1 From the Research Laboratory of the California State Department of Public Health, Berkeley

When mice are immunized by one intraperitoneal inoculation with active or inactive influenza virus (strain PR8, W.S., and Melbourne) the quantity required for protection against heterologous strains is about 10 times the homologous minimal immunizing dose. Three injections increase the immunity to all strains, but the ratio between the homologous and heterologous minimal immunizing dose is not altered.

Swine influenza virus given intraperitoneally fails to immunize against human strains unless the quantity injected is 1,000 times the minimal amount required for homologous immunity.

Intranasal immunization of mice with 1/100 M.L.D. of attenuated ferret passage strains PR8 and Philadelphia, or the tissue culture strain of swine influenza, gives a solid resistance to infection with heterologous strains. When smaller amounts of virus are given intranasally, strain specificity becomes more apparent, and with minimal doses the immunity may be effective only against the homologous and closely related strains.

 Submitted on August 8, 1940


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS